Company Filing History:
Years Active: 2015-2025
Title: Martin Weisser: Innovator in Combination Therapies
Introduction
Martin Weisser is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of medical treatments, particularly in the area of combination therapies for various disorders. With a total of three patents to his name, Weisser's work focuses on innovative approaches to treating complex health conditions.
Latest Patents
Weisser's latest patents include groundbreaking inventions aimed at improving treatment outcomes for patients with CD20-positive cell proliferative disorders. One of his notable patents involves dosing for combination treatment with an anti-CD20/anti-CD3 bispecific antibody and an anti-CD79B antibody drug conjugate. This invention specifically addresses the treatment of subjects suffering from B cell proliferative disorders, such as non-Hodgkin's lymphomas. Another significant patent relates to the treatment of tumors using an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after the failure of previous anti-PD-L1/PD1 treatments. This innovative approach aims to enhance therapeutic efficacy for patients who have not responded to standard treatments.
Career Highlights
Throughout his career, Martin Weisser has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical therapies.
Collaborations
Weisser has collaborated with esteemed colleagues such as Frieder Bauss and Birgit Bossenmaier. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Martin Weisser stands out as a dedicated inventor whose work in combination therapies has the potential to transform treatment options for patients with complex disorders. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.